Country Websites

The Fresenius Medical Care Foundation has granted funds to the American Transplant Foundation to launch LIVING+, a new U.S. initiative to expand access to living donor kidney transplantation.  

This early investment supports patient navigation, education, and virtual care—helping address inequities in the transplant system that disproportionately affect minority and underserved communities. Through culturally responsive education, peer mentorship, and in‑home virtual transplant visits, LIVING+ brings expert guidance directly to patients, making the transplant journey more accessible, equitable, and easier to navigate. As part of this work, ATF will recruit and train Spanish‑speaking mentors to better support Latino patients, with success measured by the number of identified Latino patients who complete culturally sensitive virtual transplant house calls. 

Through its investment in the American Society of Transplantation (AST), the Fresenius Medical Care Foundation is partnering with AST to survey organ transplant recipients about their experiences with current immunosuppressant agents. Insights gained from the survey will inform strategies to improve patient-reported outcomes.

The survey is designed to pinpoint and address unmet patient needs associated with immunosuppressive medications for people who have undergone organ transplantation. By offering transplant recipients the opportunity to share their experiences with anti-rejection medications, the survey aims to spur patient-centered innovation in immunosuppressive treatments that are centered around the patient's perspective.

DLA is focused on increasing the number of donated organs, eyes, and tissue available to save and heal lives.

Through its investment in the United Network for Organ Sharing (UNOS), the Fresenius Medical Care Foundation is partnering with UNOS to uncover and implement improvements in transportation and logistics for organ donation. 
The Foundation is also supporting UNOS’ research study examining the relationship between race and ethnicity, and social determinants of health  (SDoH) in post-kidney transplant outcomes. This study will help to advance the Foundation and UNOS’s shared mission to address health disparities by ensuring that patients have improved transplant outcomes irrespective of these factors.